Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v1-EN
Language French English
Date Updated 2021-07-15 2020-10-22
Drug Identification Number 02125439 02125439
Brand name CARBOPLATIN INJECTION CARBOPLATIN INJECTION
Common or Proper name CARBOPLATIN INJECTION 10MG/ML CARBOPLATIN INJECTION 10MG/ML
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients CARBOPLATIN CARBOPLATIN
Strength(s) 10MG 10MG
Dosage form(s) LIQUID LIQUID
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 5ML, 45ML 5ML
ATC code L01XA L01XA
ATC description OTHER ANTINEOPLASTIC AGENTS OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-10-21 2020-10-21
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments